香港股市 將在 50 分鐘 開市

Stryker Corporation (SYK)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
325.50-2.95 (-0.90%)
收市:04:00PM EDT
334.50 +9.00 (+2.76%)
收市後: 06:53PM EDT

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
269 385 2600
https://www.stryker.com

版塊Healthcare
行業Medical Devices
全職員工52,000

高階主管

名稱頭銜支付行使價出生年份
Mr. Kevin A. LoboChairman, CEO & President5.7M33.71M1965
Mr. Glenn S. BoehnleinVP & CFO2.27M5.44M1962
Mr. Viju S. MenonGroup President of Global Quality & Operations1.68M1968
Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology2.03M2.69M1974
Mr. Spencer S. StilesGroup President of Orthopaedics & Spine2.02M2.33M1977
Mr. William E. Berry Jr.VP & Chief Accounting Officer1966
Mr. Robert C. CohenCTO and VP of Global R&D - Joint Replacement
Mr. Alan DouvilleVP, Chief Information Officer & Chief Information Security Officer
Mr. Jason BeachVice President of Finance & Investor Relations
Mr. Robert S. FletcherVP & Chief Legal Officer895.89k1971
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

公司管治

截至 2024年5月1日 止,Stryker Corporation 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中:5;董事會:5;股東權利:6;現金賠償:4。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。